Sign in

CIK 0001712762 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

bioAffinity Technologies, Inc.

Sign in to watch
Ticker
BIAF
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465211056
Phone
210-698-5334
Business address
3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
Former names
bioAffinity Technologies, Inc.

Securities

  • BIAF Common Stock Nasdaq
  • BIAFW Warrant Nasdaq
  1. 4 Grant or award Executive Chairman acquired 54,707 shares (grant or award)
  2. 8-K Event Executive or director change
  3. 4 Grant or award Director acquired 28,392 shares (grant or award)
  4. 4 Grant or award Director acquired 28,392 shares (grant or award)
  5. 4 Grant or award Director acquired 28,392 shares (grant or award)
  6. 4 Grant or award Executive Chairman acquired 28,392 shares (grant or award)
  7. 4 Grant or award Director acquired 28,392 shares (grant or award)
  8. 4 Grant or award President, CEO acquired 54,570 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 52,356 shares (grant or award)
  10. 4 Grant or award Director acquired 28,392 shares (grant or award)
  11. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  12. 8-K Event Results of operations
  13. 10-Q Report Quarterly Report
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Executive or director change · Other events
  16. DEF 14A Proxy Proxy Statement
  17. 8-K Event Other events
  18. PRE 14A Proxy Proxy Statement (Preliminary)
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 8-K Event Other events

Page 16 of 21 · 401 filings